Response of Fibroblastic Rheumatism to Infliximab

Response of Fibroblastic Rheumatism to Infliximab

Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of c...

Full description

Bibliographic Details
Main Authors: Ricardo Romiti, Mauricio Levy Neto, Marcello Menta Simonsen Nico
Format: Article
Language:English
Published: Hindawi Limited 2009-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2009/715729
id doaj-d8fa81949cfa4164994d9eb1861c912d
record_format Article
spelling doaj-d8fa81949cfa4164994d9eb1861c912d2020-11-24T20:59:49ZengHindawi LimitedDermatology Research and Practice1687-61051687-61132009-01-01200910.1155/2009/715729715729Response of Fibroblastic Rheumatism to InfliximabRicardo Romiti0Mauricio Levy Neto1Marcello Menta Simonsen Nico2Departments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, BrazilDepartments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, BrazilDepartments of Dermatology and Rheumatology, University of São Paulo, 05403-000 São Paulo, SP, BrazilOnset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.http://dx.doi.org/10.1155/2009/715729
collection DOAJ
language English
format Article
sources DOAJ
author Ricardo Romiti
Mauricio Levy Neto
Marcello Menta Simonsen Nico
spellingShingle Ricardo Romiti
Mauricio Levy Neto
Marcello Menta Simonsen Nico
Response of Fibroblastic Rheumatism to Infliximab
Dermatology Research and Practice
author_facet Ricardo Romiti
Mauricio Levy Neto
Marcello Menta Simonsen Nico
author_sort Ricardo Romiti
title Response of Fibroblastic Rheumatism to Infliximab
title_short Response of Fibroblastic Rheumatism to Infliximab
title_full Response of Fibroblastic Rheumatism to Infliximab
title_fullStr Response of Fibroblastic Rheumatism to Infliximab
title_full_unstemmed Response of Fibroblastic Rheumatism to Infliximab
title_sort response of fibroblastic rheumatism to infliximab
publisher Hindawi Limited
series Dermatology Research and Practice
issn 1687-6105
1687-6113
publishDate 2009-01-01
description Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression. Treatment is generally unrewarding. Here we report a severe and disabling case of FR responding favorably to infliximab therapy. After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.
url http://dx.doi.org/10.1155/2009/715729
work_keys_str_mv AT ricardoromiti responseoffibroblasticrheumatismtoinfliximab
AT mauriciolevyneto responseoffibroblasticrheumatismtoinfliximab
AT marcellomentasimonsennico responseoffibroblasticrheumatismtoinfliximab
_version_ 1716781358530953216

Similar Items